Quarterly report [Sections 13 or 15(d)]

Stock-Based Compensation

v3.25.2
Stock-Based Compensation
6 Months Ended
Jun. 30, 2025
Stock-Based Compensation [Abstract]  
STOCK-BASED COMPENSATION
M. STOCK-BASED COMPENSATION:

 

In November 2021, the board of directors adopted the Amended and Restated 2021 Equity Incentive Plan (the “2021 Plan”) which provides for the granting of non-qualified stock options and restricted stock to the Company’s employees, officers, directors, and outside consultants to purchase shares of the Company’s common stock. As of June 30, 2025, the number of shares of common stock available for issuance under the 2021 Plan is 983,905 shares of common stock.

 

Stock-based compensation expense included the following components:

 

    Three Months Ended
June 30,
    Six Months Ended
June 30,
 
    2025     2024     2025     2024  
Stock options   $ 2     $ 17     $ 10     $ 17  
Restricted stock     29       3       30       153  
    $ 31     $ 20     $ 40       170  

 

All stock-based compensation expense is recorded in general and administrative expense in the unaudited condensed consolidated statements of operations.

 

Stock Options

 

The fair value of options is estimated on the date of grant using the Black-Scholes option pricing model. The fair value is amortized as compensation cost on a straight-line basis over the requisite service period of the awards, which is generally the vesting period. Expected volatility is based on historical volatility from a representative sample of publicly traded companies. The expected term represents the period of time that the options are expected to be outstanding. The risk-free interest rate is estimated using the rate of return on U.S. Treasury Notes with a life that approximates the expected life of the option. Stock-based compensation is based on awards that are ultimately expected to vest.

 

Option awards are generally granted with an exercise price equal to the fair value of the Company’s stock at the date of grant; those options generally vest based on four years of continuous service and have 10-year contractual terms.

A summary of option activity under the 2021 Plan as of and for the six months ended June 30, 2025 is presented below:

 

Options   Shares     Weighted Average
Exercise Price
    Aggregate Intrinsic
Value
 
Outstanding at December 31, 2024     1,376,333     $ 4.03     $
 
Granted     45,000       1.34      
 
Forfeited or expired and other adjustments     (17,167 )     3.72      
 
Outstanding at June 30, 2025     1,404,166     $ 3.91     $ 16  
Vested and exercisable at June 30, 2025     1,261,167     $ 4.02     $ 7  

 

The weighted-average remaining contractual term for the options outstanding and exercisable is approximately 6.6 years and 6.5 years, respectively, as of June 30, 2025.

 

Restricted Stock

 

Restricted stock consists of time-based restricted stock units (“RSUs”) and performance-based restricted stock units (PSUs). RSUs granted under the 2021 Plan generally vest over 3 to 4 years, based on continued employment, and are settled upon vesting with shares of the Company’s common stock on a one-for-one basis. PSUs granted under the 2021 Plan are issued and vest immediately as various performance goals and targets are achieved.

 

A summary of restricted stock activity under the 2021 Plan as of and for the six months ended June 30, 2025 is presented below:

 

Restricted Stock   Time-Based
RSUs
 
Outstanding at December 31, 2024     4,000  
Granted     48,347  
Vested     (24,000 )
Forfeited    
 
Outstanding at June 30, 2025     28,347